Suppr超能文献

慢性服用吲哚洛尔和普萘洛尔期间及之后人体循环淋巴细胞β-肾上腺素能受体特征变化及反应性的比较

Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.

作者信息

Giudicelli Y, Lacasa D, Agli B, Leneveu A

出版信息

Eur J Clin Pharmacol. 1984;26(1):7-12. doi: 10.1007/BF00546700.

Abstract

The characteristics of the beta-adrenoceptors (3H-dihydroalprenolol binding) and the beta-adrenergic responsiveness (cyclic AMP response to isoproterenol) were studied in circulating lymphocytes from healthy volunteers before (D 0), on the 22nd day of treatment (D 22) and on the fifth day (D 30) following discontinuation of pindolol 15 mg/day or propranolol 160 mg/day. During pindolol therapy (D 22) the beta-adrenoceptor-affinity towards dihydroalprenolol was unchanged and the beta-adrenoceptor density decreased by 50%, an effect which persisted after drug administration ceased (D 30). The receptor "down-regulation" was accompanied by a parallel decrease in the maximal lymphocyte response to isoproterenol on D 22 and 30, by a shift to the right of the concentration-response curves to isoproterenol on D 22 and 30. In contrast, no significant modification in beta-adrenoceptor density or in the maximal response to isoproterenol was observed during (D 22) or after discontinuation (D 30) or propranolol therapy; the beta-adrenoceptor affinity for dihydroalprenolol and the sensitivity of the lymphocyte response to isoproterenol were markedly reduced on D 22 but not on D 30. It is concluded that the lymphocyte beta-adrenoceptor "down regulation" and the parallel beta-adrenergic desensitization induced by chronic pindolol therapy are both due to the intrinsic sympathomimetic activity of this drug.

摘要

在健康志愿者中,研究了每日服用15mg吲哚洛尔或160mg普萘洛尔前(第0天)、治疗第22天(D22)以及停药后第5天(D30)循环淋巴细胞中β-肾上腺素能受体(³H-二氢烯丙洛尔结合)的特征和β-肾上腺素能反应性(异丙肾上腺素引起的环磷酸腺苷反应)。在吲哚洛尔治疗期间(D22),β-肾上腺素能受体对二氢烯丙洛尔的亲和力未变,β-肾上腺素能受体密度降低了50%,停药后(D30)这种效应仍持续存在。受体“下调”伴随着D22和D30时淋巴细胞对异丙肾上腺素的最大反应平行降低,以及D22和D30时异丙肾上腺素浓度-反应曲线右移。相比之下,在普萘洛尔治疗期间(D22)或停药后(D30),未观察到β-肾上腺素能受体密度或对异丙肾上腺素的最大反应有显著改变;D22时β-肾上腺素能受体对二氢烯丙洛尔的亲和力和淋巴细胞对异丙肾上腺素反应的敏感性显著降低,但D30时未降低。结论是,慢性吲哚洛尔治疗诱导的淋巴细胞β-肾上腺素能受体“下调”和平行的β-肾上腺素能脱敏均归因于该药物的内在拟交感活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验